UMC: Price Hikes in 2026–2027; 12nm US Output in 2027
According to a shareholder meeting held on May 27, wafer foundry leader United Microelectronics Corporation (UMC) outlined its first-quarter financial performance, announced key technology cooperation milestones with Intel, and confirmed a phased pricing strategy adjustment amid rising cost pressures, alongside continued expansion into advanced packaging and silicon photonics to capture new long-term growth drivers.
Strong Q1 performance with high utilization in advanced nodes
UMC reported a solid start to 2026. According to its late-April financial disclosure, first-quarter consolidated revenue reached NT$61.04 billion, while net profit attributable to shareholders surged 107.8% year-on-year to NT$16.17 billion, with earnings per share of NT$1.29.
From a technology mix perspective, 22/28nm processes accounted for 34% of total revenue, with 22nm alone reaching a record 14%. The company expects more than 50 customer tape-outs on its 22nm platform by the end of the year, spanning display driver ICs, networking chips, and microcontroller applications.
Capacity utilization remains tight. Overall utilization is around 85%, while 12-inch fabs in Singapore and Xiamen are operating above the company average, approaching full capacity. Management noted that second-half performance is expected to improve over the first half, driven by recovering 8-inch demand, rising 22nm contribution, and a broader market recovery.
To differentiate amid intensified competition in mature-node manufacturing in mainland China, UMC continues to focus on specialty process technologies, while expanding value-added offerings in areas such as silicon photonics and compound semiconductors.
12nm FinFET cooperation with Intel targets 2027 production
At the same shareholder meeting, Co-CEO Wang Shi provided a clear timeline for the closely watched collaboration with Intel. The 12nm FinFET platform has completed technology transfer, and pilot validation is underway at Intel’s Arizona facility.
The project is expected to complete process qualification in 2026, with mass production targeted for the second half of 2027. Initial customer tape-outs are anticipated in 2027.
Wang emphasized that this cooperation represents more than a technology transfer, marking UMC’s deeper integration into the US-based semiconductor supply chain. The company also signaled openness to future collaboration on more advanced process nodes.
Industry observers suggest the partnership may deliver three strategic benefits: expanded access to the US market, stronger positioning within US semiconductor manufacturing ecosystems, and a continued upgrade path beyond 22nm for customers transitioning to 12nm platforms.
Selective price increases in 2H26, broader adjustments expected in 2027
On pricing strategy, CFO Liu Chi-tung clarified that UMC is not pursuing opportunistic price hikes, but rather aligning pricing with increased investments in technology upgrades, supply chain resilience, and global capacity expansion.
Cost pressures have increased due to higher raw material costs, elevated operating expenses in Singapore, and ongoing R&D investment.
The pricing roadmap is structured as follows:
Existing long-term contracts: fully honored without price changes
Second half of 2026: selective and moderate price adjustments for new orders, new process nodes, and new wafer starts
2027: potential for broader pricing discussions, with a shift toward value-based pricing negotiations with customers
Liu noted that customers generally understand current industry cost dynamics. Market expectations suggest that if broader price adjustments are implemented in 2027, the increase could exceed the level seen in 2026.
Singapore expansion, silicon photonics, and advanced packaging progress
UMC’s Singapore expansion remains a key pillar of its global strategy. Fab 12i currently operates at approximately 12,000–13,000 wafers per month, primarily supporting 22/28nm production. Capacity is expected to expand to 18,000 wafers per month. The external structure of the P4 facility has already been completed, and future production may include specialty processes, silicon photonics, and selected advanced nodes.
In silicon photonics, UMC has obtained technology licensing from imec and has entered pilot production for its 12-inch silicon photonics platform. The company is also targeting next-generation high-speed interconnect applications compatible with co-packaged optics (CPO), with risk production expected between 2026 and 2027.
In advanced packaging, UMC is focusing on wafer-related packaging technologies. Silicon interposer capacity has doubled from 3,000 to 6,000 wafers per month using 55nm and 60nm process technologies. Future expansion will depend on customer demand and next-generation platform requirements.
Outlook toward 2027: multiple growth drivers converge
Looking ahead to 2027, UMC expects several key milestones to align: mass production of the 12nm platform in cooperation with Intel, gradual ramp-up of Singapore capacity expansion, and the transition of silicon photonics and advanced packaging into customer qualification and risk production stages.
Combined with anticipated pricing adjustments, these developments are expected to strengthen the company’s growth trajectory. Management emphasized that the semiconductor industry is entering a new upgrade cycle, with UMC positioning itself to capture value across both mature and specialty process technologies.
